Literature DB >> 2706831

The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

A Albini1, S L Aukerman, R C Ogle, D M Noonan, R Fridman, G R Martin, I J Fidler.   

Abstract

The invasive and metastatic characteristics of cloned cells derived from the K-1735 murine melanoma were investigated. Cell lines which are highly metastatic in mice were found to be invasive in vitro, and to show an enhanced attachment to, spreading on and migration toward laminin. As attachment, spreading and directional migration are thought to be receptor-mediated events, the binding of laminin to these cells was studied. Biotinylated laminin was used to evaluate receptor binding by fluorescence activated cell sorting (FACS) and this method was compared with that in which the binding of radioactive laminin is measured. Both studies revealed that metastatic K-1735 cells (a) have more receptors for laminin compared with non-metastatic cells and (b) exhibit a second population of low-affinity binding sites not present on the non-metastatic cells. The differences in receptor number and type may account for the greater interaction of metastatic cells with laminin and their invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706831     DOI: 10.1007/BF01753664

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  45 in total

Review 1.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

2.  Laminin increases the release of type IV collagenase from malignant cells.

Authors:  T Turpeenniemi-Hujanen; U P Thorgeirsson; C N Rao; L A Liotta
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

Review 3.  Basement membrane and the invasive activity of metastatic tumor cells.

Authors:  V P Terranova; E S Hujanen; G R Martin
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

4.  Laminin receptors for neurite formation.

Authors:  H K Kleinman; R C Ogle; F B Cannon; C D Little; T M Sweeney; L Luckenbill-Edds
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  The cellular interactions of laminin fragments. Cell adhesion correlates with two fragment-specific high affinity binding sites.

Authors:  M Aumailley; V Nurcombe; D Edgar; M Paulsson; R Timpl
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

Review 6.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

7.  Fibronectin: purification, immunochemical properties, and biological activities.

Authors:  E Ruoslahti; E G Hayman; M Pierschbacher; E Engvall
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

8.  Attachment to and degradation of collagen substrata by adenovirus-transformed cells of varying tumorigenicity.

Authors:  E L Levine; D E Birk; K Raska
Journal:  Coll Relat Res       Date:  1984-01

9.  Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading.

Authors:  S L Goodman; R Deutzmann; K von der Mark
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

10.  Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells.

Authors:  H L Malinoff; M S Wicha
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

View more
  16 in total

1.  Laminin-induced retinoblastoma cell differentiation: possible involvement of a 100-kDa cell-surface laminin-binding protein.

Authors:  A Albini; D M Noonan; A Melchiori; G F Fassina; M Percario; S Gentleman; J Toffenetti; G J Chader
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

Review 3.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

Authors:  S Taniguchi; T Iwamura; N Kitamura; H Yamanari; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

Review 5.  Are cellular adhesion molecules involved in the metastasis of breast cancer?

Authors:  M Maemura; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  The invasive phenotypes.

Authors:  M M Mareel; F M Van Roy; P De Baetselier
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

7.  Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.

Authors:  K Koretz; P Schlag; L Boumsell; P Möller
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

8.  Expression of beta 1 integrins in non-neoplastic mammary epithelium, fibroadenoma and carcinoma of the breast.

Authors:  G Mechtersheimer; M Munk; T Barth; K Koretz; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.

Authors:  C L Slingluff; K R Stidham; W M Ricci; W E Stanley; H F Seigler
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

10.  The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.

Authors:  E W Thompson; N Brünner; J Torri; M D Johnson; V Boulay; A Wright; M E Lippman; P S Steeg; R Clarke
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.